10 research outputs found
COX7A2L genetic variants determine cardiorespiratory fitness in mice and human
Benegiamo et al. identify genetic variants of the mitochondrial supercomplex assembly factor COX7A2L in the skeletal muscle of mice and humans that promote cardiorespiratory fitness.Mitochondrial respiratory complexes form superassembled structures called supercomplexes. COX7A2L is a supercomplex-specific assembly factor in mammals, although its implication for supercomplex formation and cellular metabolism remains controversial. Here we identify a role for COX7A2L for mitochondrial supercomplex formation in humans. By using human cis-expression quantitative trait loci data, we highlight genetic variants in the COX7A2L gene that affect its skeletal muscle expression specifically. The most significant cis-expression quantitative trait locus is a 10-bp insertion in the COX7A2L 3 ' untranslated region that increases messenger RNA stability and expression. Human myotubes harboring this insertion have more supercomplexes and increased respiration. Notably, increased COX7A2L expression in the muscle is associated with lower body fat and improved cardiorespiratory fitness in humans. Accordingly, specific reconstitution of Cox7a2l expression in C57BL/6J mice leads to higher maximal oxygen consumption, increased lean mass and increased energy expenditure. Furthermore, Cox7a2l expression in mice is induced specifically in the muscle upon exercise. These findings elucidate the genetic basis of mitochondrial supercomplex formation and function in humans and show that COX7A2L plays an important role in cardiorespiratory fitness, which could have broad therapeutic implications in reducing cardiovascular mortality.Peer reviewe
COX7A2L genetic variants determine cardiorespiratory fitness in mice and human
Benegiamo et al. identify genetic variants of the mitochondrial supercomplex assembly factor COX7A2L in the skeletal muscle of mice and humans that promote cardiorespiratory fitness.Mitochondrial respiratory complexes form superassembled structures called supercomplexes. COX7A2L is a supercomplex-specific assembly factor in mammals, although its implication for supercomplex formation and cellular metabolism remains controversial. Here we identify a role for COX7A2L for mitochondrial supercomplex formation in humans. By using human cis-expression quantitative trait loci data, we highlight genetic variants in the COX7A2L gene that affect its skeletal muscle expression specifically. The most significant cis-expression quantitative trait locus is a 10-bp insertion in the COX7A2L 3 ' untranslated region that increases messenger RNA stability and expression. Human myotubes harboring this insertion have more supercomplexes and increased respiration. Notably, increased COX7A2L expression in the muscle is associated with lower body fat and improved cardiorespiratory fitness in humans. Accordingly, specific reconstitution of Cox7a2l expression in C57BL/6J mice leads to higher maximal oxygen consumption, increased lean mass and increased energy expenditure. Furthermore, Cox7a2l expression in mice is induced specifically in the muscle upon exercise. These findings elucidate the genetic basis of mitochondrial supercomplex formation and function in humans and show that COX7A2L plays an important role in cardiorespiratory fitness, which could have broad therapeutic implications in reducing cardiovascular mortality
The mouse metallomic landscape of aging and metabolism
International audienceOrganic elements make up 99% of an organism but without the remaining inorganic bioessential elements, termed the metallome, no life could be possible. The metallome is involved in all aspects of life, including charge balance and electrolytic activity, structure and conformation, signaling, acid-base buffering, electron and chemical group transfer, redox catalysis energy storage and biomineralization. Here, we report the evolution with age of the metallome and copper and zinc isotope compositions in five mouse organs. The aging metallome shows a conserved and reproducible fingerprint. By analyzing the metallome in tandem with the phenome, metabolome and proteome, we show networks of interactions that are organ-specific, age-dependent, isotopically-typified and that are associated with a wealth of clinical and molecular traits. We report that the copper isotope composition in liver is age-dependent, extending the existence of aging isotopic clocks beyond bulk organic elements. Furthermore, iron concentration and copper isotope composition relate to predictors of metabolic health, such as body fat percentage and maximum running capacity at the physiological level, and adipogenesis and OXPHOS at the biochemical level. Our results shed light on the metallome as an overlooked omic layer and open perspectives for potentially modulating cellular processes using careful and selective metallome manipulation
Identification of Immune-Responsive Gene 1 (IRG1) as a Target of A20
A20
is a negative regulator of NF-ÎșB signaling; it controls
inflammatory responses and ensures tissue homeostasis. A20 is thought
to restrict NF-ÎșB activation both by its ubiquitin-editing activity
as well as by its nonenzymatic activities. Besides its role in NF-ÎșB
signaling, A20 also acts as a protective factor inhibiting apoptosis
and necroptosis. Because of the ability of A20 to both ubiquitinate
and deubiquitinate substrates, and its involvement in many cellular
processes, we hypothesized that deletion of A20 might generally impact
on protein levels, thereby disrupting cellular signaling. We performed
a differential proteomics study on bone marrow-derived macrophages
(BMDMs) from control and myeloid-specific A20 knockout mice, both
in untreated conditions and after LPS or TNF treatment, and demonstrated
A20-dependent changes in protein expression. Several inflammatory
proteins were found up-regulated in the absence of A20, even without
an inflammatory stimulus, but, depending on the treatment and the
treatment time, more proteins were found regulated. Together these
protein changes may affect normal signaling events, which may disturb
tissue homeostasis and induce (autoimmune) inflammation, in agreement
with A20s proposed identity as a susceptibility gene for inflammatory
disease. We further verify that immune-responsive gene 1 (IRG1) is
up-regulated in the absence of A20 and that its levels are transcriptionally
regulated
Identification of Immune-Responsive Gene 1 (IRG1) as a Target of A20
A20
is a negative regulator of NF-ÎșB signaling; it controls
inflammatory responses and ensures tissue homeostasis. A20 is thought
to restrict NF-ÎșB activation both by its ubiquitin-editing activity
as well as by its nonenzymatic activities. Besides its role in NF-ÎșB
signaling, A20 also acts as a protective factor inhibiting apoptosis
and necroptosis. Because of the ability of A20 to both ubiquitinate
and deubiquitinate substrates, and its involvement in many cellular
processes, we hypothesized that deletion of A20 might generally impact
on protein levels, thereby disrupting cellular signaling. We performed
a differential proteomics study on bone marrow-derived macrophages
(BMDMs) from control and myeloid-specific A20 knockout mice, both
in untreated conditions and after LPS or TNF treatment, and demonstrated
A20-dependent changes in protein expression. Several inflammatory
proteins were found up-regulated in the absence of A20, even without
an inflammatory stimulus, but, depending on the treatment and the
treatment time, more proteins were found regulated. Together these
protein changes may affect normal signaling events, which may disturb
tissue homeostasis and induce (autoimmune) inflammation, in agreement
with A20s proposed identity as a susceptibility gene for inflammatory
disease. We further verify that immune-responsive gene 1 (IRG1) is
up-regulated in the absence of A20 and that its levels are transcriptionally
regulated
Identification of Immune-Responsive Gene 1 (IRG1) as a Target of A20
A20
is a negative regulator of NF-ÎșB signaling; it controls
inflammatory responses and ensures tissue homeostasis. A20 is thought
to restrict NF-ÎșB activation both by its ubiquitin-editing activity
as well as by its nonenzymatic activities. Besides its role in NF-ÎșB
signaling, A20 also acts as a protective factor inhibiting apoptosis
and necroptosis. Because of the ability of A20 to both ubiquitinate
and deubiquitinate substrates, and its involvement in many cellular
processes, we hypothesized that deletion of A20 might generally impact
on protein levels, thereby disrupting cellular signaling. We performed
a differential proteomics study on bone marrow-derived macrophages
(BMDMs) from control and myeloid-specific A20 knockout mice, both
in untreated conditions and after LPS or TNF treatment, and demonstrated
A20-dependent changes in protein expression. Several inflammatory
proteins were found up-regulated in the absence of A20, even without
an inflammatory stimulus, but, depending on the treatment and the
treatment time, more proteins were found regulated. Together these
protein changes may affect normal signaling events, which may disturb
tissue homeostasis and induce (autoimmune) inflammation, in agreement
with A20s proposed identity as a susceptibility gene for inflammatory
disease. We further verify that immune-responsive gene 1 (IRG1) is
up-regulated in the absence of A20 and that its levels are transcriptionally
regulated
Growth differentiation factor 15 protects against the aging-mediated systemic inflammatory response in humans and mice
Mitochondrial dysfunction is associated with aging-mediated inflammatory responses, leading to metabolic deterioration, development of insulin resistance, and type 2 diabetes. Growth differentiation factor 15 (GDF15) is an important mitokine generated in response to mitochondrial stress and dysfunction; however, the implications of GDF15 to the aging process are poorly understood in mammals. In this study, we identified a link between mitochondrial stress-induced GDF15 production and protection from tissue inflammation on aging in humans and mice. We observed an increase in serum levels and hepatic expression ofGDF15as well as pro-inflammatory cytokines in elderly subjects. Circulating levels of cell-free mitochondrial DNA were significantly higher in elderly subjects with elevated serum levels of GDF15. In the BXD mouse reference population, mice with metabolic impairments and shorter survival were found to exhibit higher hepaticGdf15expression. Mendelian randomization links reducedGDF15expression in human blood to increased body weight and inflammation. GDF15 deficiency promotes tissue inflammation by increasing the activation of resident immune cells in metabolic organs, such as in the liver and adipose tissues of 20-month-old mice. Aging also results in more severe liver injury and hepatic fat deposition inGdf15-deficient mice. Although GDF15 is not required for Th17 cell differentiation and IL-17 production in Th17 cells, GDF15 contributes to regulatory T-cell-mediated suppression of conventional T-cell activation and inflammatory cytokines. Taken together, these data reveal that GDF15 is indispensable for attenuating aging-mediated local and systemic inflammation, thereby maintaining glucose homeostasis and insulin sensitivity in humans and mice